MAP1LC3A (N-term) Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-MAP1LC3A (N-term) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityMAP1LC3A (N-term)
Clonepolyclonal
Host SpeciesRabbit
Reactive Specieshuman, mouse, ratpredicted: zebrafish, bovine
Isotypen/a
FormatProtein A purified
Size0.05 mL, 0.2 mL
Concentrationn/a
ApplicationsWestern Blot (WB), ELISA (EIA)
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionThis antibody is generated from a rabbit immunized with a KLH conjugated synthetic peptide between 1-40 amino acids from human. Ubiquitin-like modifier involved in formation of autophagosomal vacuoles (autophagosomes). Whereas LC3s are involved in elongation of the phagophore membrane, the GABARAP/GATE-16 subfamily is essential for a later stage in autophagosome maturation.
Immunogenn/a
Other Names[Microtubule-associated proteins 1A/1B light chain 3A; Autophagy-related protein LC3 A; Autophagy-related ubiquitin-like modifier LC3 A; MAP1 light chain 3-like protein 1; MAP1A/MAP1B light chain 3 A; MAP1A/MAP1B LC3 A; Microtubule-associated protein 1 light chain 3 alpha; MAP1LC3A]
Gene, Accession #[MAP1LC3A], Gene ID: 84557, NCBI: Q9H492.2, UniProt: Q9H492
Catalog #MBS9231349
Price$165, $370
Order / More InfoMAP1LC3A (N-term) Antibody from MYBIOSOURCE INC.
Product Specific ReferencesHe H.,et al.J. Biol. Chem. 278:29278-29287(2003). Kalnine N.,et al.Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases. Bechtel S.,et al.BMC Genomics 8:399-399(2007). Deloukas P.,et al.Nature 414:865-871(2001). Mural R.J.,et al.Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.